AngioDynamics, Inc.AngioDynamics, Inc.AngioDynamics, Inc.

AngioDynamics, Inc.

No trades
See on Supercharts
Market capitalization
‪252.74 M‬USD
−4.78USD
‪−52.44 M‬USD
‪338.75 M‬USD
‪38.63 M‬
Beta (1Y)
0.87

About AngioDynamics, Inc.

CEO
James Christopher Clemmer
Headquarters
Latham
Employees (FY)
815
Founded
1988
ISIN
US03475V1017
FIGI
BBG000BB5621
AngioDynamics, Inc. operates as a medical device company, which engages in the development, manufacturing and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It operates through the Med Tech and Med Device segments. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ANGO is featured.

Frequently Asked Questions

The current price of ANGO is 6.39 USD — it has increased by 1.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange AngioDynamics, Inc. stocks are traded under the ticker ANGO.
AngioDynamics, Inc. is going to release the next earnings report on Jul 10, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for AngioDynamics, Inc. has a max estimate of 18.00 USD and a min estimate of 10.00 USD.
ANGO earnings for the last quarter are −0.05 USD whereas the estimation was −0.07 USD which accounts for 32.16% surprise. Estimated earnings for the next quarter are −0.16 USD. See more details about AngioDynamics, Inc. earnings.
AngioDynamics, Inc. revenue for the last quarter amounts to ‪79.07 M‬ USD despite the estimated figure of ‪81.16 M‬ USD. In the next quarter revenue is expected to reach ‪74.21 M‬ USD.
Yes, you can track AngioDynamics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ANGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AngioDynamics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ANGO reached its all-time high on Nov 5, 2021 with the price of 32.00 USD, and its all-time low was 5.26 USD and was reached on Mar 25, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 815.00 employees. See our rating of the largest employees — is AngioDynamics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AngioDynamics, Inc. EBITDA is ‪−1.41 M‬ USD, and current EBITDA margin is 4.28%. See more stats in AngioDynamics, Inc. financial statements.